Possible indications for vitamin D₃ analogues in conditions other than psoriasis vulgaris

References

• Langner A, Verjans H, Stapor V, et al. 1α,25-dihydroxyvitamin D3 (calcitriol) ointment in psoriasis. J Dermatol Treat 1992; 3: 177–80
   Google Scholar
• Nishimura M, Hori Y, Nishiyama S, et al. Topical 1α,24(R) dihydroxy vitamin D3 for the treatment of psoriasis. Review of the literature. Eur J Dermatol 1993; 3: 255–61
   Google Scholar
• Kragballe K, Iversen L. Calcipotriol: a new topical antipsoriatic. Dermatol Ther 1993; 11: 137–44
   Google Scholar
• Ramsay C A, Berth-Jones J, Brundin G, et al. Long-term use of topical calcipotriol in chronic plaque psoriasis. Dermatology 1994; 189: 260–1
   PubMed Web of Science ®Google Scholar
• Poyner T, Hughes I W, Dass BK, et al. Long-term treatment of chronic plaque psoriasis with calcipotriol. J Dermatol Treat 1993; 4: 173–7
   Google Scholar
• Ozono K, Sone T, Pike JW. The genomic mechanism of action of 1,25-dihydroxyvitamin D3. J Bone Miner Res 1991; 6: 1021–7
   PubMed Web of Science ®Google Scholar
• Kliewer S A, Umesone K, Mangelsdorf DJ, et al. Retinoid X receptor interacts with nuclear receptors in retinoic acid, thyroid hormone and vitamin D3 signalling. Nature 1992; 355: 446–9
   PubMed Web of Science ®Google Scholar
• Carlberg C, Bendik I, Wyss A, et al. Two nuclear signalling pathways for vitamin D. Nature 1993; 361: 657–60
   PubMed Web of Science ®Google Scholar
• Bittiner B, Bleehan S S, MacNeil S. 1α,25-(OH)2-vitamin D3 increases intracellular calcium in human keratinocytes. Br J Dermatol 1991; 124: 230–5
   PubMed Web of Science ®Google Scholar
• Pillai S, Bikle D D, Elias PM. 1,25-Dihydroxyvitamin D production and receptor binding in human keratinocytes varies with differentiation. J Biol Chem 1988; 263: 5390–5
   PubMed Web of Science ®Google Scholar
• Mac Laughlin J A, Cantley L C, Holick MF. 1,25(OH)2D3 increases calcium and phosphatidylinositol metabolism in differentiating cultured human keratinocytes. J Nutr Biochem 1990; 1: 81–7
   Google Scholar
• Yada Y, Ozeki T, Meguro S. Signal transduction in the onset of terminal keratinocyte differentiation induced by 1α,25-dihydroxyvitamin D3: role of protein kinase C translocation. Biochem Biophys Res Commun 1989; 163: 1517–22
   Google Scholar
• Binderup L, Bramm E. Effects of a novel vitamin D analogue MC903 on cell proliferation and differentiation in vitro and on calcium metabolism in vivo. Biochem Pharmacol 1988; 37: 889–95
   PubMed Web of Science ®Google Scholar
• Kragballe K, Wildfang IL. Calcipotriol (MC903), a novel vitamin D3 analogue, stimulates terminal differentiation and inhibits proliferation of cultured human keratinocytes. Arch Dermatol Res 1990; 282: 164–7
   PubMed Web of Science ®Google Scholar
• Hosomi J, Hosoi J, Abe E, et al. Regulation of terminal differentiation of cultured mouse epidermal cells by 1α,25-dihydroxyvitamin D3. Endocrinology 1983; 113: 1950–7
   PubMed Web of Science ®Google Scholar
• Smith E L, Walworth N C, Holick MF. Effect of 1α,25-dihydroxyvitamin D3 on the morphological and biochemical differentiation of cultured human epidermal keratinocytes grown in serum-free conditions. J Invest Dermatol 1986; 86: 709–14
   PubMed Web of Science ®Google Scholar
• Holick MF. Vitamin D: biosynthesis, metabolism and mode of action. Endocrinology., LJ De Groot. Grune and Stratton, New York 1989; 902–26
   Google Scholar
• Regnier M, Darmon M. 1,25-Dihydroxyvitamin D3 stimulates specifically the last steps of epidermal differentiation of cultured human keratinocytes. Differentiation 1991; 47: 173–88
   PubMed Web of Science ®Google Scholar
• Lee S C, Ikai K, Ando Y, Imamura S. Effects of 1 alpha, 25-dihydroxyvitamin D3 on the transglutaminase activity of transformed mouse epidermal cells in culture. J Dermatol 1989; 16: 7–11
   Google Scholar
• Abe J, Nakano T, Nishii Y, et al. A novel vitamin D3 analogue, 22-oxa-1,25-dihydroxyvitamin D3, inhibits the growth of human breast cancer in vitro and in vivo without causing hypercalcemia. Endocrinology 1991; 129: 832–7
   PubMed Web of Science ®Google Scholar
• Tsoukas C D, Provvedini D M, Manolagas SC. 1,25-Dihydroxy-vitamin D3: a novel immunoregulatory hormone. Science 1984; 224: 1438–40
   PubMed Web of Science ®Google Scholar
• Lemire JM. Immunomodulatory role of 1,25-dihydroxy-vitamin D3. J Cell Biochem 1992; 49: 26–31
   PubMed Web of Science ®Google Scholar
• Tani M, Murata Y, Harada S, et al. Increased contact hypersensitivity response in mice by topical application of 1 alpha, 25-dihydroxyvitamin D3 to elicitation site. Arch Dermatol Res 1989; 281: 355–61
   PubMedGoogle Scholar
• Hustmyer F G, Benniger L, Manolagas SC. Comparison of the effects of 22-oxa-1,25(OH)2D3 and MC903 on the production of IL-6, γ-IFN and T lymphocyte proliferation in peripheral blood mononuclear cells. J Bone Miner Res 1991; 6: S292, abstract
   Google Scholar
• Oberg F, Botling J, Nilsson K. Functional antagonism between vitamin D3 and retinoic acid in the regulation of CD14 and CD23 expression during monocytic differentiation of U-937 cells. J Immunol 1993; 150: 3487–95
   PubMed Web of Science ®Google Scholar
• Tokuda N, Mizuki N, Kasahara M, et al. 1,25-hydroxyvitamin D3 down-regulation of HLA-DR on human peripheral blood monocytes. Immunology 1992; 75: 349–54
   PubMedGoogle Scholar
• Tanaka Y, Klauck T M, Jubiz W. In vivo effects of 1,25-dihydroxy-vitamin D3 and minerals on the synthesis of leukotriene B4 and 5-hydroxyeicosatetraenoic acid by rat peritoneal neutrophils. Prostaglandins Leukot Essent Fatty Acids 1988; 32: 9–14
   PubMedGoogle Scholar
• Zhou J Y, Norman A W, Lübbert M, et al. Novel vitamin D analogues that modulate leukemic cell growth and differentiation with little effect on either intestinal calcium absorption or bone mobilization. Blood 1989; 74: 82–93
   PubMed Web of Science ®Google Scholar
• de Jong EJ MG, van de Kerkhof P CM. Simultaneous assessment of inflammation and epidermal proliferation in psoriatic plaques during long-term treatment with the vitamin D3 analogue MC903: modulations and interrelations. Br J Dermatol 1991; 124: 221–9
   PubMed Web of Science ®Google Scholar
• Gerritsen M JP, Boezeman J BM, van Vlijmen-Willems IJ MJ, et al. The effect of tacalcitol (1,24-(OH)2D3) on cutaneous inflammation, epidermal proliferation and keratinization in psoriasis: a placebo-controlled, double-blind study. Br J Dermatol 1994; 131: 57–63
   PubMed Web of Science ®Google Scholar
• Gerritsen M JP, Rulo H FC, van Vlijmen-Willems, et al. Topical treatment of psoriatic plaques with 1,25-dihydroxycholecalciferol: a cell biological study. Br J Dermatol 1993; 128: 666–73
   PubMedGoogle Scholar
• Berth-Jones J, Bourke J, Baily K, et al. Generalised pustular psoriasis: response to topical calcipotriol. BMJ 1992; 305: 868–9
   PubMedGoogle Scholar
• Kuypers A, van Dooren-Greebe R J, van de Kerkhof P CM. Acrodermatitis continua Hallopeau: response to combined treatment with acitretin and calcipotriol ointment. Dermatology, in press
   Google Scholar
• Kragballe K, Steylen P M, Ibsen HH, et al. Efficacy, tolerability and safety of calcipotriol ointment in disorders of keratinization. Arch Dermatol 1995; 131: 556–60
   PubMed Web of Science ®Google Scholar
• Lucker G, Steylen P M, van de Kerkhof P CM. Calcipotriol in the treatment of congenital ichthyosis. Br J Dermatol 1994; 131: 546–50
   PubMed Web of Science ®Google Scholar
• Lucker G PH, van de Kerkhof P CM, Cruysberg J RM, et al. Topical treatment of Sjögren-Larsson syndrome with calcipotriol, a clinical study. Dermatology 1995; 190: 242–4
   Google Scholar
• Van de Kerkhof P CM, Steylen PM. Topical treatment of pityriasis rubra pilaris with calcipotriol. Br J Dermatol 1994; 130: 675–8
   PubMedGoogle Scholar
• Lucker G PH, van de Kerkhof P CM, Steylen PM. Calcipotriol in the treatment of palmoplantor keratoderma of the epidermolytic type (Vömer). Br J Dermatol 1994; 130: 543–5
   PubMed Web of Science ®Google Scholar
• Gatti S, Carozzo A M, Orlandi A, et al. Treatment of inflammatory linear verrucous epidermal naevus with calcipotriol. Br J Dermatol 1995; 132: 837–9
   PubMedGoogle Scholar
• de Jong E MGJ, Rulo H FC, van de Kerkhof P CM. Inflammatory verrucous epidermal naevus (ILVEN) versus linear psoriasis; a clinical histological and immunohistochemical study. Acta Derm Venereal (Stockh) 1991; 71: 343–6
   Google Scholar
• Keohane S G, Cork MJ. Treatment of Grover's disease with calcipotriol (DovonexR). Br J Dermatol 1995; 132: 832–3
   Google Scholar